References
- Turnbull F. Effects of different blood‐pressure‐lowering regimens on major cardiovascular events: Results of prospectively‐designed overviews of randomised trials. Lancet 2003; 362: 1527–1535
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252
- Chapman N, Chang CL, Dahlof B, Sever PS, Wedel H, Poulter NR. Effect of doxazosin gastrointestinal therapeutic system as third‐line antihypertensive therapy on blood pressure and lipids in the Anglo‐Scandinavian Cardiac Outcomes Trial. Circulation 2008; 118: 42–48
- Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M. Usefulness of the alpha1‐blocker doxazosin as a third‐line antihypertensive drug. Hypertens Res 2007; 30: 301–306
- ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid‐lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000; 283: 1967–1975
- Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: 510–526
- Black HR, Sollins JS, Garofalo JL. The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: a randomized, placebo‐controlled study. Am J Hypertens 2000; 13: 468–474
- Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, et al. Clinical efficacy and tolerability of alpha‐blocker doxazosin as add‐on therapy in patients with hypertension and impaired glucose metabolism. Nutr Metab Cardiovasc Dis 2006; 16: 137–147
- Guzik P, Wykretowicz A, Krauze T, Piskorski J, Adamska K, Milewska A, et al. Add‐on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system. Hypertens Res 2008; 31: 443–453